100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human Parkinson Disease Protein 2 (PARK2) ELISA Kit (HUDL02190)

SKU HUDL02190
Product Type ELISA Kit
Size 96 Assays
Uniprot O60260
Sensitivity 0.053ng/mL
Range 0.156-10ng/mL
ELISA Type Sandwich
Synonyms AR-JP,LPRS2,PDJ,PRKN,Parkin,Autosomal Recessive,Juvenile,E3 ubiquitin-protein ligase parkin
Reactivity Human
Sample Type Tissue Homogenates And Other Biological Fluids
$1,138

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Human Parkinson Disease Protein 2 (PARK2) ELISA Kit

The Human PARK2 (Parkinson Disease Protein 2) ELISA Kit is specifically designed for the precise measurement of PARK2 levels in human biological samples, including serum, plasma, and cell culture supernatants. This kit offers exceptional sensitivity and specificity, ensuring accurate and consistent results for various research applications.PARK2, also known as Parkin, is a critical protein implicated in Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain.

Dysfunctional PARK2 has been linked to the pathogenesis of Parkinson's disease, making it a vital biomarker for studying the disease mechanisms and exploring potential therapeutic interventions.By utilizing the Human PARK2 ELISA Kit, researchers can delve deeper into the role of PARK2 in Parkinson's disease and other neurodegenerative conditions, ultimately advancing our understanding of these debilitating disorders and paving the way for new treatment strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose